MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$3,956K
Free Cash flow
-$12,458K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Non-cash operating lease expense
Prepaid expenses and other asset...
Others
Negative Cash Flow Breakdown
Purchase of marketable securitie...
Net loss
Accretion of discounts on market...
Operating lease liabilities
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-17,580
-34,808
Accretion of discounts on marketable securities
735
1,533
Depreciation and amortization
205
480
Stock-based compensation expense
5,029
9,185
Non-cash operating lease expense
478
1,168
Prepaid expenses and other assets
-438
1,615
Accounts payable, accrued expenses and other current liabilities
328
-91
License fees payable
0
-35,000
Operating lease liabilities
-621
-1,471
Net cash used in operating activities
-12,458
-63,685
Purchase of marketable securities
47,743
138,652
Proceeds from maturities of marketable securities
56,209
74,410
Purchase of property and equipment
0
83
Net cash (used in) provided by investing activities
8,466
-64,325
Proceeds from issuances of common stock in 'at-the-market' offerings, net of issuance costs
0
0
Proceeds from issuance of common stock under employee stock plans
36
161
Net cash provided by financing activities
36
161
Net decrease in cash and cash equivalents
-3,956
-127,849
Cash and cash equivalents at beginning of period
169,735
-
Cash and cash equivalents at end of period
37,930
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of marketable...
$56,209K
Proceeds from issuance of
common stock under...
$36K
Net cash (used in)
provided by investing...
$8,466K
Net cash provided by
financing activities
$36K
Canceled cashflow
$47,743K
Net decrease in cash
and cash...
-$3,956K
Canceled cashflow
$8,502K
Stock-based compensation
expense
$5,029K
Non-cash operating lease
expense
$478K
Prepaid expenses and
other assets
-$438K
Accounts payable,
accrued expenses and...
$328K
Depreciation and
amortization
$205K
Purchase of marketable
securities
$47,743K
Net cash used in
operating activities
-$12,458K
Canceled cashflow
$6,478K
Net loss
-$17,580K
Accretion of discounts on
marketable securities
$735K
Operating lease
liabilities
-$621K
Buy us a coffee
RAPT Therapeutics, Inc. (RAPT)
RAPT Therapeutics, Inc. (RAPT)